Amazon One Medical vs Gala Health
Two GLP-1 desks, one scoreboard. We put Amazon One Medical and Gala Health head-to-head on the published Brief Score — the same six factors, scored the same way.
Amazon One Medical
The verdict
Amazon One Medical takes this head-to-head.
Amazon One Medical scores 86 to 82 on our six-factor Brief Score — The most recognizable name in the ranking — Amazon's One Medical routes brand-name GLP-1 care through real primary-care clinicians, but keeps pricing off the record.
That doesn't make Gala Health a bad call — it's best for readers ready to commit to a year of compounded tirzepatide up front, who want it available in all 50 states and like knowing a brand-name ozempic route exists if they ever switch — and who value a menopause/hrt program alongside the glp-1. Weigh the six factors below against your own priorities before you decide.
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.
Factor by factor
Both desks scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.
Price, coverage & the tracker
| Amazon One Medical | Gala Health | |
|---|---|---|
| Brief Score | 86/100 (B) | 82/100 (B−) |
| Semaglutide | Not disclosed | Not disclosed |
| Tirzepatide | Not disclosed | $179/mo (yearly subscription) |
| Coverage | All 50 states | All 50 states |
| Brand-name access | Yes | Yes |
| Oral / sublingual | Injection only | Injection only |
| On the tracker | Stableprice stable | Stableprice stable |
Amazon One Medical: Brand-access model through One Medical clinicians; compounded pricing isn't published, so there's no sticker to track.
Gala Health: Headline compounded-tirz rate unchanged this cycle, but it is a yearly-subscription price — the shortest published plan is three months at $199/mo, and no month-to-month rate exists.
● Not sold on either?
CoreAge Rx tops the whole ranking at 94/100.
The steadiest desk in the ranking: one flat, no-step-up price on both molecules, nationwide, and it hasn't moved.
Keep comparing
Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.